Oral ulcer revision 1

•Download as PPT, PDF•

28 likes•2,149 views

This document lists and briefly describes various oral diseases and conditions that can cause lesions in the mouth. It mentions traumatic ulcers, recurrent aphthous ulcers, major aphthous ulcers associated with Behcet's syndrome, erythema nodosum, pathergy testing, Reiter's syndrome, squamous cell carcinoma, tuberculosis, syphilis in its secondary and tertiary forms, primary herpetic gingivostomatitis, recurrent herpes labialis, herpetic whitlow, recurrent intraoral herpes, chickenpox, herpes zoster, hand-foot-and-mouth disease, herpangina, erythema multiforme minor, Stevens-Johnson

Behcet syndrome
(mucocutaneous occular
syndrome)

Chicken pox(primariy varicella
zoster infection)

What's hot

Oral ulcersAnhar Al-gebaly

Aphthous ulcers

anila namboodiripad

Primary oral ulcerative lesions newAhmed Shakora

Ulcerative , vascular , bollous lesions

Fayrooz Habib

Ulceration slides-090331Shaymaa Rafat

Sur mucosal lesions

NINAN THOMAS

Lect.1.mouth cavity

Mohanad Mohanad

Priya seminar on ulcerative,vesicular and bullous lesionspriyadershini rangari

Omd 411Anhar Al-gebaly

Aphthous Ulcerdentist

Solitary oral ulcers and systemic diseases

Dr. Harsh Shah

White& red lesionsAnhar Al-gebaly

Vesiculo bullous I

IAU Dent

Ulcerative & inflammatory diseases of oral cavity i nMohammad Manzoor

Vesicular and bullous lesions power point

Moh Adnan

Oral ulcers

Marwa Khalifa

oral mucosal diseases 2010LE HAI TRIEU

Ulcerative condiion

IAU Dent

Mucosal Disease

jeff_burgess_dds_msd

Ulcerative & inflammatory diseases of oral cavity i

Be a Good Doctor Ali Dirie

What's hot (20)

Oral ulcers

Aphthous ulcers

Primary oral ulcerative lesions new

Ulcerative , vascular , bollous lesions

Ulceration slides-090331

Sur mucosal lesions

Lect.1.mouth cavity

Priya seminar on ulcerative,vesicular and bullous lesions

Omd 411

Aphthous Ulcer

Solitary oral ulcers and systemic diseases

White& red lesions

Vesiculo bullous I

Ulcerative & inflammatory diseases of oral cavity i n

Vesicular and bullous lesions power point

Oral ulcers

oral mucosal diseases 2010

Ulcerative condiion

Mucosal Disease

Ulcerative & inflammatory diseases of oral cavity i

Viewers also liked

Oral cavity lesionsNotre Dame De Chartres Hospital

Whit lesionsAnhar Al-gebaly

Pigmentation todayAnhar Al-gebaly

White lesions(collection)Anhar Al-gebaly

White lesions pptAnhar Al-gebaly

Ulcers

Sadru mohamed

Classification Of Dental Caries

shabeel pn

Chinastyle

Heixin 黑心

Les 2 leven in een kennis, netwerk en risicomijwimerkelbout

Story of a Tiny Frog - The Achiever

Gurpreet Tikku

New microsoft power point presentation

Uzma Waqas

Amlexanox use in aphthous ulcer

Harikesh Maurya

Most people suffer with a mouth ulcer every now and then. They're extremely common and usually painful, appearing as little craters in the lining of the mouth. Mouth plays a significant role in moment-to-moment living. And even a minor oral problem can cause significant eating, drinking or communicating health consequences. Imagine, if mouth is constantly taking in potentially mouth harming substances by way of the air you breath, the food that’s munched down on, those teeth picking fingers or bacterial and virus infection causing material allowed to pass through lips. However, not all oral infections, pain or sores originate externally. Some diseases and disorders can be the genesis for trouble. Mouth problems are a universal experience. In this regards, finally we find that the Amlexanox is effective in reducing aphthous ulcer, pain and lesional size.

Deveo

Securing online services by combining smart cards and web-based applicationsOlivier Potonniée

Dev ops 2016 dockerizing the it

Deveo

List+of+pharm+journals

mahendra21pharmacy

Viewers also liked (16)

Oral cavity lesions

Whit lesions

Pigmentation today

White lesions(collection)

White lesions ppt

Ulcers

Classification Of Dental Caries

Chinastyle

Les 2 leven in een kennis, netwerk en risicomij

Story of a Tiny Frog - The Achiever

New microsoft power point presentation

Amlexanox use in aphthous ulcer

Deveo

Securing online services by combining smart cards and web-based applications

Dev ops 2016 dockerizing the it

List+of+pharm+journals

Recently uploaded

THERAPEUTIC ANTISENSE MOLECULES .pptx

70KRISHPATEL

Light House Retreats: Plant Medicine Retreat Europe

Lighthouse Retreat

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx

Swetaba Besh

Physiology of Special Chemical Sensation of Taste

MedicoseAcademics

Title: Sense of Taste Presenter: Dr. Faiza, Assistant Professor of Physiology Qualifications: MBBS (Best Graduate, AIMC Lahore) FCPS Physiology ICMT, CHPE, DHPE (STMU) MPH (GC University, Faisalabad) MBA (Virtual University of Pakistan) Learning Objectives: Describe the structure and function of taste buds. Describe the relationship between the taste threshold and taste index of common substances. Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation. Recognize different abnormalities of taste perception and their causes. Key Topics: Significance of Taste Sensation: Differentiation between pleasant and harmful food Influence on behavior Selection of food based on metabolic needs Receptors of Taste: Taste buds on the tongue Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper) Primary and Secondary Taste Sensations: Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami Chemical basis and signal transduction mechanisms for each taste Taste Threshold and Index: Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine) Taste index relationship: Inversely proportional to taste threshold Taste Blindness: Inability to taste certain substances, particularly thiourea compounds Example: Phenylthiocarbamide Structure and Function of Taste Buds: Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers Location of Taste Buds: Found in papillae of the tongue (Fungiform, Circumvallate, Foliate) Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus Mechanism of Taste Stimulation: Interaction of taste substances with receptors on microvilli Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes Taste Sensitivity and Adaptation: Decrease in sensitivity with age Rapid adaptation of taste sensation Role of Saliva in Taste: Dissolution of tastants to reach receptors Washing away the stimulus Taste Preferences and Aversions: Mechanisms behind taste preference and aversion Influence of receptors and neural pathways Impact of Sensory Nerve Damage: Degeneration of taste buds if the sensory nerve fiber is cut Abnormalities of Taste Detection: Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia) Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels Neurotransmitters and Taste Threshold: Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity Supertasters: 25% of the population with heightened sensitivity to taste, especially bitterness Increased number of fungiform papillae

Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun

chandankumarsmartiso

Identification and nursing management of congenital malformations .pptx

MGM SCHOOL/COLLEGE OF NURSING

263778731218 Abortion Clinic /Pills In Harare ,

sisternakatoto

263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade

Prof. Marcus Renato de Carvalho

Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva. Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade. Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal. Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural. Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis. É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais. O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada. Recomendamos muito. Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos. Esta publicação só está disponível em inglês até o momento. Prof. Marcus Renato de Carvalho www.agostodourado.com

DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY

NEHA GUPTA

The process of drug discovery and development is a complex and multi-step endeavor aimed at bringing new pharmaceutical drugs to market. It begins with identifying and validating a biological target, such as a protein, gene, or RNA, that is associated with a disease. This step involves understanding the target's role in the disease and confirming that modulating it can have therapeutic effects. The next stage, hit identification, employs high-throughput screening (HTS) and other methods to find compounds that interact with the target. Computational techniques may also be used to identify potential hits from large compound libraries. Following hit identification, the hits are optimized to improve their efficacy, selectivity, and pharmacokinetic properties, resulting in lead compounds. These leads undergo further refinement to enhance their potency, reduce toxicity, and improve drug-like characteristics, creating drug candidates suitable for preclinical testing. In the preclinical development phase, drug candidates are tested in vitro (in cell cultures) and in vivo (in animal models) to evaluate their safety, efficacy, pharmacokinetics, and pharmacodynamics. Toxicology studies are conducted to assess potential risks. Before clinical trials can begin, an Investigational New Drug (IND) application must be submitted to regulatory authorities. This application includes data from preclinical studies and plans for clinical trials. Clinical development involves human trials in three phases: Phase I tests the drug's safety and dosage in a small group of healthy volunteers, Phase II assesses the drug's efficacy and side effects in a larger group of patients with the target disease, and Phase III confirms the drug's efficacy and monitors adverse reactions in a large population, often compared to existing treatments. After successful clinical trials, a New Drug Application (NDA) is submitted to regulatory authorities for approval, including all data from preclinical and clinical studies, as well as proposed labeling and manufacturing information. Regulatory authorities then review the NDA to ensure the drug is safe, effective, and of high quality, potentially requiring additional studies. Finally, after a drug is approved and marketed, it undergoes post-marketing surveillance, which includes continuous monitoring for long-term safety and effectiveness, pharmacovigilance, and reporting of any adverse effects.

ABDOMINAL TRAUMA in pediatrics part one.

drhasanrajab

Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.

Superficial & Deep Fascia of the NECK.pptx

Dr. Rabia Inam Gandapore

Chapter 11 Nutrition and Chronic Diseases.pptx

Earlene McNair

Management of Traumatic Splenic injury.pptx

AkshaySarraf1

Physiology of Chemical Sensation of smell.pdf

MedicoseAcademics

Title: Sense of Smell Presenter: Dr. Faiza, Assistant Professor of Physiology Qualifications: MBBS (Best Graduate, AIMC Lahore) FCPS Physiology ICMT, CHPE, DHPE (STMU) MPH (GC University, Faisalabad) MBA (Virtual University of Pakistan) Learning Objectives: Describe the primary categories of smells and the concept of odor blindness. Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction. Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain. Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential. Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes. Key Topics: Olfactory Genes: 3% of the human genome accounts for olfactory genes. 400 genes for odorant receptors. Olfactory Membrane: Located in the superior part of the nasal cavity. Medially: Folds downward along the superior septum. Laterally: Folds over the superior turbinate and upper surface of the middle turbinate. Total surface area: 5-10 square centimeters. Olfactory Mucosa: Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell. Sustentacular Cells: Produce mucus and maintain ionic and molecular environment. Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months. Bowman’s Gland: Secretes mucus. Stimulation of Olfactory Cells: Odorant dissolves in mucus and attaches to receptors on olfactory cilia. Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve. Quality of a Good Odorant: Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble. Facilitated by odorant-binding proteins in mucus. Membrane Potential and Action Potential: Resting membrane potential: -55mV. Action potential frequency in the olfactory nerve increases with odorant strength. Adaptation Towards the Sense of Smell: Rapid adaptation within the first second, with further slow adaptation. Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system. Primary Sensations of Smell: Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid. Odor Detection Threshold: Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm). Some toxic substances are odorless at lethal concentrations. Characteristics of Smell: Odor blindness for single substances due to lack of appropriate receptor protein. Behavioral and emotional influences of smell. Transmission of Olfactory Signals: From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition. Primitive, less old, and new olfactory systems with different path

share - Lions, tigers, AI and health misinformation, oh my!.pptx

Tina Purnat

• Pitfalls and pivots needed to use AI effectively in public health • Evidence-based strategies to address health misinformation effectively • Building trust with communities online and offline • Equipping health professionals to address questions, concerns and health misinformation • Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach

Ayurveda ForAll

Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS

AkankshaAshtankar

The Best Ayurvedic Antacid Tablets in India

Swastik Ayurveda

Tests for analysis of different pharmaceutical.pptx

taiba qazi

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...

Oleg Kshivets

Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).